US lawmakers tackle safety reforms at the FDA.
Zwillich
Todd
T
D016265:Conflict of Interest; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics*; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D016861:Cyclooxygenase Inhibitors